Condition: Bipolar Disorder Type I With Mania or Mania With Mixed Features · Sponsor: Bristol-Myers Squibb
This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an acute episode of mania or mania with mixed features. The primary objective of the study is to evaluate the efficacy of KarXT compared to placebo in treating symptoms of mania during a 3-week inpatient period. The duration of the study including screening, the double-blind inpatient treatment period and safety-follow-up is no more than seven weeks.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Pillar Clinical Research- Little Rock | Little Rock, Arkansas, United States | Recruiting |
| Woodland Research Northwest | Rogers, Arkansas, United States | Recruiting |
| Proscience Research Group | Culver City, California, United States | Recruiting |
| Clinical Innovations, Inc. dba CITrials | Riverside, California, United States | Recruiting |
| Collaborative Neuroscience Research, LLC | Torrance, California, United States | Recruiting |
| Local Institution - 0036 | Hialeah Gardens, Florida, United States | Withdrawn |
| Behavioral Clinical Research | Hollywood, Florida, United States | Recruiting |
| LCC Medical Research Institute | Miami, Florida, United States | Recruiting |
| Innovative Clinical Research, Inc. | Miami Lakes, Florida, United States | Recruiting |
| South Florida Research Phase I-IV | Miami Springs, Florida, United States | Recruiting |
| Local Institution - 0019 | Tampa, Florida, United States | Withdrawn |
| Health Synergy Clinical Research | West Palm Beach, Florida, United States | Recruiting |
+ 73 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06951711